The mechanism by which aneuploid tumors inactivate Stat1 signaling to suppress immune infiltration is preserved and functional in human aneuploid cancers, indicating that this pathway represents a conserved evolutionary solution for chromosomally unstable cells to achieve malignant transformation. [@schubert_cancer_2021]

Definitions

Synthesis

The inactivation of Stat1 signaling in aneuploid tumors represents a conserved evolutionary strategy across both mouse models and human cancers to evade the immune surveillance that chromosomal instability normally triggers. This mechanism is consistently coupled with increased Myc activity, forming a dual adaptation that allows chromosomally unstable tumor cells to suppress the immune cell infiltration that would otherwise limit their proliferation and malignancy. While the mechanistic relationship between Stat1 loss, Myc activation, and immune evasion in aneuploid cancers is well-established across species, what remains less clear is whether this represents the only viable pathway for aneuploid cells to overcome immune-mediated fitness costs, given that p53 loss—despite being common in many cancers—is notably not enriched in chromosomally unstable tumors specifically.

Bibliography